Siemens 2011 Annual Report Download - page 295

153 D. Consolidated Financial Statements 273 E. Additional information
158 D. Consolidated Statements of Changes in Equity
160 D. Notes to Consolidated Financial Statements
266 D. Supervisory Board and Managing Board
154 D. Consolidated Statements of Income
155 D. Consolidated Statements of Comprehensive Income
156 D. Consolidated Statements of Financial Position
157 D. Consolidated Statements of Cash Flow

In fiscal , Capital Meters Holdings Ltd., an investment ac-
counted under the equity method, held by Energy was sold.
The gain is reported in Income (loss) from investments ac-
counted for using the equity method, net. Regarding the sale
of the % minority stake in Dräger Medical AG & Co. KG see
Note  Acquisitions, dispositions and discontinued opera-
tions.
Our interest in BSH, which is the principal jointly controlled
entity of Siemens, is recognized using the equity method, as
described in
Note  Summary of significant accounting poli-
cies, applying BSH’s twelve month periods ended June . The
following information reflect BSH’s most recent published fi-
nancial statements, not adjusted for the percentage of owner-
ship held by Siemens.
Year ended December ,
(in millions of €)  
Revenue 9,073 8,405
Net income (loss) 467 328
December ,
(in millions of €)  
Current assets 4,019 3,797
Non-current assets 2,882 2,646
Current liabilities 2,838 2,170
Non-current liabilities 1,655 1,738
Summarized financial information for our principal invest-
ments in associates, not adjusted for the percentage of own-
ership held by Siemens, is presented below. Income state-
ment information is presented for the twelve month period
applied under the equity method of accounting.
Year ended September ,
(in millions of €)  
Revenue 20,359 18,346
Net income (loss) (432) (980)
Information related to the Statements of Financial Position is
presented as of the date used in applying the equity method
of accounting.
September ,
(in millions of €)  
Total assets 18,967 16,770
Total liabilities 12,843 11,784
For information on contingent liabilities for joint ventures and
associates see
Note 39 Related party transactions.
Regarding the fiscal  conversion of our loan receivable
from NSN into interests in NSN’s preferred shares and regard-
ing Siemens’ contribution of new equity in exchange for pre-
ferred shares in NSN see
Note 39 Related party transactions.
 – Other financial assets
September ,
(in millions of €)  
Loans receivable 4,396 3,032
Receivables from finance leases, see
Note 12 Trade and other receivables 2,983 3,094
Derivative financial instruments 2,153 2,693
Available-for-sale financial assets 714 486
Other 1,609 1,460
11,855 10,765
Item Loans receivable primarily relate to long-term loan trans-
actions of SFS. As of September , , item Loans receiv-
able includes a shareholder loan to NSN granted in fiscal
; regarding the conversion of our loan to NSN into shares
in NSN in fiscal  see
Note 39 Related party transactions.
Regarding item Derivative financial instruments see
Note 31
Additional disclosures on financial instruments and
Note 32
Derivative financial instruments and hedging activities.
For additional information regarding available-for-sale finan-
cial assets classified as non-current see
Note 11 Available-
for-sale financial assets.